Diuretic Comparison Project
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 20723 participants.
Also called NCT02185417
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 20,723 participants
- Registry
-
NCT02185417
-
- Main results
- Chlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular Events
- Other papers using this trial's data
- A Centralized EHR-Based Model for the Recruitment of Rural and Lower Socioeconomic Participants in Pragmatic Trials: A Secondary Analysis of the Diuretic Comparison Project
- Chlorthalidone vs Hydrochlorothiazide and Kidney Outcomes in Patients With Hypertension: A Secondary Analysis of a Randomized Clinical Trial
- Chlorthalidone vs Hydrochlorothiazide for Hypertension Treatment After Myocardial Infarction or Stroke: A Secondary Analysis of a Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Puerto Rico
- Registry status
- Completed
Technical summary
Registry record NCT02185417. Randomized; no masking; primary purpose treatment. Start 2016-06-15 (actual); primary completion 2022-10-15 (actual). Results posted on 2024-05-22.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Diuretic Comparison Project
- Acronym
- DCP
- Condition
- Hypertension
- Intervention (Drug)
- Hydrochlorothiazide (HCTZ)
- Intervention (Drug)
- Chlorthalidone (CTD)
- Lead sponsor
- VA Office of Research and Development
Record details
- Record id
cardio:ct-nct02185417- Content hash
ac9ac861bf67c2fef64c1dadf0abe811c31052e8e98d5709d9e53b501cd5da9c